Odyssey Therapeutics, Inc. ODTX
Set alert
19.53 USD -0.01 -0.05%
At close · Nov 2
19.53 0.00 0.00%
After hours · Nov 2, 4:00 PM ET
18.72 Day range 20.66
15.10 52-week range 29.05
- YTD
- +18.94%
- 1 year
- +18.94%
- Open
- 19.83
- Prev close
- 19.54
- Mkt cap
- 938.58M
- Vol
- 258.94K
- Avg vol
- 261.85K
- EPS
- -7.55
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 18.72
- High
- 20.66
- Forward P/E
- -4.78
- Beta
- 0.00
- Short ratio
- 11.58
- Inst. own
- 83.08%
- Dividend
- 0.00
- Ex-div date
- Earnings
- Nov 4, 2026
- 50-d avg
- 22.53
- 200-d avg
- 19.92
- 1y target
- 35.75
Analyst view
Consensus: none
Price target (mean) 35.75 +83.1% upside
Now 19.53
- Target (low)
- 29.00
- Target (mean)
- 35.75
- Target (high)
- 44.00
Ratings (0m) 6 6 buy · 0 hold · 0 sell
- Strong buy1
- Buy5
- Hold0
- Sell0
- Strong sell0
Recommendation trend
- This month 6
- 1 month ago 6
- 2 months ago 5
Earnings and revenue estimates
Consensus for the coming quarters and fiscal years
| Period | EPS estimate | Low – high | Year ago | EPS growth | Revenue estimate | Revenue growth | Analysts |
|---|---|---|---|---|---|---|---|
| Current quarter | -0.93023 | -1.07 – -0.81 | 0.00 | 0.0% | 0 | 0.0% | 3 |
| Next quarter | -1.01 | -1.17 – -0.85 | 0.00 | 0.0% | 0 | 0.0% | 3 |
| Current year | -4.26 | -4.55 – -3.89 | 0.00 | 0.0% | 0 | 0.0% | 3 |
| Next year | -4.36 | -5.08 – -3.45 | -4.26 | -2.5% | 0 | 0.0% | 3 |
Upgrades and downgrades
The latest rating changes
| Date | Firm | Action | From | To |
|---|---|---|---|---|
| Aug 27, 2026 | HC Wainwright & Co. | Initiated | — | Buy |
| Aug 7, 2026 | JP Morgan | Maintained | Overweight | Overweight |
| Jun 18, 2026 | Oppenheimer | Reiterated | Outperform | Outperform |
| Jun 2, 2026 | Cantor Fitzgerald | Initiated | — | Overweight |
| Jun 2, 2026 | TD Cowen | Initiated | — | Buy |
| Jun 2, 2026 | Wedbush | Initiated | — | Outperform |
| Jun 2, 2026 | JP Morgan | Initiated | — | Overweight |
| Jun 2, 2026 | Oppenheimer | Initiated | — | Outperform |